Do Intravenous N-Acetylcysteine and Sodium Bicarbonate Prevent High Osmolal Contrast-Induced Acute Kidney Injury? A Randomized Controlled Trial

Detalhes bibliográficos
Autor(a) principal: Inda-Filho, Antonio Jose
Data de Publicação: 2014
Outros Autores: Caixeta, Adriano, Manggini, Marcia, Schor, Nestor [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://repositorio.unifesp.br/handle/11600/38229
http://dx.doi.org/10.1371/journal.pone.0107602
Resumo: Background: N-acetylcysteine (NAC) or sodium bicarbonate (NaHCO3), singly or combined, inconsistently prevent patients exposed to radiographic contrast media from developing contrast-induced acute kidney injury (CI-AKI).Objective: We asked whether intravenous isotonic saline and either NaHCO3 in 5% dextrose or else a high dose of NAC in 5% dextrose prevent CI-AKI in outpatients exposed to high-osmolal iodinated contrast medium more than does saline alone.Methods: This completed prospective, parallel, superiority, open-label, controlled, computer-randomized, single-center, Brazilian trial (NCT01612013) hydrated 500 adult outpatients (214 at high risk of developing CI-AKI) exposed to ioxitalamate during elective coronary angiography and ventriculography. From 1 hour before through 6 hours after exposure, 126 patients (group 1) received a high dose of NAC and saline, 125 (group 2) received NaHCO3 and saline, 124 (group 3) received both treatments, and 125 (group 4) received only saline.Results: Groups were similar with respect to age, gender, weight, pre-existing renal dysfunction, hypertension, medication, and baseline serum creatinine and serum cystatin C, but diabetes mellitus was significantly less prevalent in group 1. CI-AKI incidence 72 hours after exposure to contrast medium was 51.4% (257/500), measured as serum creatinine > (baseline+0.3 mg/dL) and/or serum cystatin C > (1.1 center dot baseline), and 7.6% (38/500), measured as both serum creatinine and serum cystatin C > (baseline+0.3 mg/dL) or > (1.25 center dot baseline). CI-AKI incidence measured less sensitively was similar among groups. Measured more sensitively, incidence in group 1 was significantly (p<0.05) lower than in groups 2 and 3 but not group 4; adjustment for confounding by infused volume equalized incidence in groups 1 and 3.Conclusion
id UFSP_cc011f4e712bd02ac2920efd0634a61a
oai_identifier_str oai:repositorio.unifesp.br:11600/38229
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Inda-Filho, Antonio JoseCaixeta, AdrianoManggini, MarciaSchor, Nestor [UNIFESP]Universidade de Brasília (UnB)Hosp Israelita Albert EinsteinUniversidade Federal de São Paulo (UNIFESP)2016-01-24T14:37:53Z2016-01-24T14:37:53Z2014-09-25Plos One. San Francisco: Public Library Science, v. 9, n. 9, 9 p., 2014.1932-6203http://repositorio.unifesp.br/handle/11600/38229http://dx.doi.org/10.1371/journal.pone.0107602WOS000344862300025.pdf10.1371/journal.pone.0107602WOS:000344862300025Background: N-acetylcysteine (NAC) or sodium bicarbonate (NaHCO3), singly or combined, inconsistently prevent patients exposed to radiographic contrast media from developing contrast-induced acute kidney injury (CI-AKI).Objective: We asked whether intravenous isotonic saline and either NaHCO3 in 5% dextrose or else a high dose of NAC in 5% dextrose prevent CI-AKI in outpatients exposed to high-osmolal iodinated contrast medium more than does saline alone.Methods: This completed prospective, parallel, superiority, open-label, controlled, computer-randomized, single-center, Brazilian trial (NCT01612013) hydrated 500 adult outpatients (214 at high risk of developing CI-AKI) exposed to ioxitalamate during elective coronary angiography and ventriculography. From 1 hour before through 6 hours after exposure, 126 patients (group 1) received a high dose of NAC and saline, 125 (group 2) received NaHCO3 and saline, 124 (group 3) received both treatments, and 125 (group 4) received only saline.Results: Groups were similar with respect to age, gender, weight, pre-existing renal dysfunction, hypertension, medication, and baseline serum creatinine and serum cystatin C, but diabetes mellitus was significantly less prevalent in group 1. CI-AKI incidence 72 hours after exposure to contrast medium was 51.4% (257/500), measured as serum creatinine > (baseline+0.3 mg/dL) and/or serum cystatin C > (1.1 center dot baseline), and 7.6% (38/500), measured as both serum creatinine and serum cystatin C > (baseline+0.3 mg/dL) or > (1.25 center dot baseline). CI-AKI incidence measured less sensitively was similar among groups. Measured more sensitively, incidence in group 1 was significantly (p<0.05) lower than in groups 2 and 3 but not group 4; adjustment for confounding by infused volume equalized incidence in groups 1 and 3.ConclusionHospital das Forc, as Armadas e Instituto de Cardiologia de BrasiliaUniv Brasilia, Div Nefrol, Hosp Univ Brasilia, Brasilia, DF, BrazilHosp Israelita Albert Einstein, São Paulo, BrazilUniv Brasilia, Hosp Univ Brasilia, Brasilia, DF, BrazilUniversidade Federal de São Paulo, São Paulo, BrazilUniversidade Federal de São Paulo, EPM, São Paulo, BrazilWeb of Science9engPublic Library SciencePlos OneDo Intravenous N-Acetylcysteine and Sodium Bicarbonate Prevent High Osmolal Contrast-Induced Acute Kidney Injury? A Randomized Controlled Trialinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESPORIGINALWOS000344862300025.pdfapplication/pdf645273${dspace.ui.url}/bitstream/11600/38229/1/WOS000344862300025.pdf74fea8b0c41e2ef3b0a84ffe44eb07c7MD51open accessTEXTWOS000344862300025.pdf.txtWOS000344862300025.pdf.txtExtracted texttext/plain47460${dspace.ui.url}/bitstream/11600/38229/2/WOS000344862300025.pdf.txt53c5d01ab8261908af04116df1fbd3a4MD52open access11600/382292022-06-02 09:13:01.054open accessoai:repositorio.unifesp.br:11600/38229Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652022-06-02T12:13:01Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv Do Intravenous N-Acetylcysteine and Sodium Bicarbonate Prevent High Osmolal Contrast-Induced Acute Kidney Injury? A Randomized Controlled Trial
title Do Intravenous N-Acetylcysteine and Sodium Bicarbonate Prevent High Osmolal Contrast-Induced Acute Kidney Injury? A Randomized Controlled Trial
spellingShingle Do Intravenous N-Acetylcysteine and Sodium Bicarbonate Prevent High Osmolal Contrast-Induced Acute Kidney Injury? A Randomized Controlled Trial
Inda-Filho, Antonio Jose
title_short Do Intravenous N-Acetylcysteine and Sodium Bicarbonate Prevent High Osmolal Contrast-Induced Acute Kidney Injury? A Randomized Controlled Trial
title_full Do Intravenous N-Acetylcysteine and Sodium Bicarbonate Prevent High Osmolal Contrast-Induced Acute Kidney Injury? A Randomized Controlled Trial
title_fullStr Do Intravenous N-Acetylcysteine and Sodium Bicarbonate Prevent High Osmolal Contrast-Induced Acute Kidney Injury? A Randomized Controlled Trial
title_full_unstemmed Do Intravenous N-Acetylcysteine and Sodium Bicarbonate Prevent High Osmolal Contrast-Induced Acute Kidney Injury? A Randomized Controlled Trial
title_sort Do Intravenous N-Acetylcysteine and Sodium Bicarbonate Prevent High Osmolal Contrast-Induced Acute Kidney Injury? A Randomized Controlled Trial
author Inda-Filho, Antonio Jose
author_facet Inda-Filho, Antonio Jose
Caixeta, Adriano
Manggini, Marcia
Schor, Nestor [UNIFESP]
author_role author
author2 Caixeta, Adriano
Manggini, Marcia
Schor, Nestor [UNIFESP]
author2_role author
author
author
dc.contributor.institution.none.fl_str_mv Universidade de Brasília (UnB)
Hosp Israelita Albert Einstein
Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Inda-Filho, Antonio Jose
Caixeta, Adriano
Manggini, Marcia
Schor, Nestor [UNIFESP]
description Background: N-acetylcysteine (NAC) or sodium bicarbonate (NaHCO3), singly or combined, inconsistently prevent patients exposed to radiographic contrast media from developing contrast-induced acute kidney injury (CI-AKI).Objective: We asked whether intravenous isotonic saline and either NaHCO3 in 5% dextrose or else a high dose of NAC in 5% dextrose prevent CI-AKI in outpatients exposed to high-osmolal iodinated contrast medium more than does saline alone.Methods: This completed prospective, parallel, superiority, open-label, controlled, computer-randomized, single-center, Brazilian trial (NCT01612013) hydrated 500 adult outpatients (214 at high risk of developing CI-AKI) exposed to ioxitalamate during elective coronary angiography and ventriculography. From 1 hour before through 6 hours after exposure, 126 patients (group 1) received a high dose of NAC and saline, 125 (group 2) received NaHCO3 and saline, 124 (group 3) received both treatments, and 125 (group 4) received only saline.Results: Groups were similar with respect to age, gender, weight, pre-existing renal dysfunction, hypertension, medication, and baseline serum creatinine and serum cystatin C, but diabetes mellitus was significantly less prevalent in group 1. CI-AKI incidence 72 hours after exposure to contrast medium was 51.4% (257/500), measured as serum creatinine > (baseline+0.3 mg/dL) and/or serum cystatin C > (1.1 center dot baseline), and 7.6% (38/500), measured as both serum creatinine and serum cystatin C > (baseline+0.3 mg/dL) or > (1.25 center dot baseline). CI-AKI incidence measured less sensitively was similar among groups. Measured more sensitively, incidence in group 1 was significantly (p<0.05) lower than in groups 2 and 3 but not group 4; adjustment for confounding by infused volume equalized incidence in groups 1 and 3.Conclusion
publishDate 2014
dc.date.issued.fl_str_mv 2014-09-25
dc.date.accessioned.fl_str_mv 2016-01-24T14:37:53Z
dc.date.available.fl_str_mv 2016-01-24T14:37:53Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv Plos One. San Francisco: Public Library Science, v. 9, n. 9, 9 p., 2014.
dc.identifier.uri.fl_str_mv http://repositorio.unifesp.br/handle/11600/38229
http://dx.doi.org/10.1371/journal.pone.0107602
dc.identifier.issn.none.fl_str_mv 1932-6203
dc.identifier.file.none.fl_str_mv WOS000344862300025.pdf
dc.identifier.doi.none.fl_str_mv 10.1371/journal.pone.0107602
dc.identifier.wos.none.fl_str_mv WOS:000344862300025
identifier_str_mv Plos One. San Francisco: Public Library Science, v. 9, n. 9, 9 p., 2014.
1932-6203
WOS000344862300025.pdf
10.1371/journal.pone.0107602
WOS:000344862300025
url http://repositorio.unifesp.br/handle/11600/38229
http://dx.doi.org/10.1371/journal.pone.0107602
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Plos One
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 9
dc.publisher.none.fl_str_mv Public Library Science
publisher.none.fl_str_mv Public Library Science
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
bitstream.url.fl_str_mv ${dspace.ui.url}/bitstream/11600/38229/1/WOS000344862300025.pdf
${dspace.ui.url}/bitstream/11600/38229/2/WOS000344862300025.pdf.txt
bitstream.checksum.fl_str_mv 74fea8b0c41e2ef3b0a84ffe44eb07c7
53c5d01ab8261908af04116df1fbd3a4
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1802764133301485568